$AFCG

TANNENBAUM LEONARD M purchased $55K of AFCG

TANNENBAUM LEONARD M purchased 15,223 shares of Advanced Flower Capital Inc. (AFCG) at $3.59 on 2026-09-02.

Original reporting
SEC EDGAR · TANNENBAUM LEONARD M
Published Sep 4, 2026, 8:37 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 8:52 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AFCG
Neutral
medium confidence
Mentioned
$AFCG
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFCGNeutralLow
01

Why it matters

The disclosed purchase adds a new data point on insider sentiment for AFCG.

02

Market read

Minor relevance for traders monitoring micro‑cap insider buying trends.

03

What to watch

Potential upcoming financing or strategic moves not disclosed in the filing.

Relevance 4/10Novelty 4/10Timing: filing reported on Sep 4, 2026 (covers Sep 2 purchase)

Background

Form 4 filings disclose insider transactions; they are primary sources for insider activity.

Company-level read

Ticker impact

$AFCGNeutralMedium confidence
Context

Director Leonard Tannenbaum purchased 15,223 shares of Advanced Flower Capital Inc. for $54,650, a new Form 4 filing.

Expected impact

Limited short-term price movement expected; may provide slight upside bias.

Evidence & confidence

The purchase is a primary disclosure but under $100k, typical for micro‑cap insiders, so impact is likely minimal.

Market effects

None significant; the company operates in niche cannabis‑related finance.

No broader regional effect.

Limited to investors tracking micro‑cap insider activity.

Counterpoint

Insider purchase could be a routine portfolio adjustment rather than a bullish signal.

Key entities

  • Advanced Flower Capital Inc.

    Issuer of the Form 4 filing.

  • Leonard Tannenbaum

    Director and 10% owner of AFCG.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AFCGMed

Advanced Flower Capital (AFCG) Q2 2026 Earnings Call Transcript

Advanced Flower Capital (AFCG) reported Q2 2026 net investment income of $3.5M, or $0.15 per share, with NAV per share rising to $8.25. The company repurchased 839,406 shares and has a $1.3B investment pipeline. Management highlighted rising default rates in private credit and challenges in the cannabis industry. AFCG is resolving nonaccrual loans and focusing on lower middle market borrowers.

$AFCGMed

Advanced Flower Capital Inc. (AFCG): Results of Operations and Financial Condition

Advanced Flower Capital Inc. (AFCG) filed an SEC Form 8-K — Results of Operations and Financial Condition. AFC Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net investment income (“NII”) of $3.5 million, or $0.15 per weighted average share WEST PALM BEACH, FL, August 13, 2026 – Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) tod

$AFCGMed

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) said it committed $7.0 million to a $25.0 million senior secured credit facility, including a term loan and delayed draw term loan. An AFC affiliate will add $5.0 million, for $12.0 million total. Proceeds will refinance existing capital and fund acquisitions for an outpatient behavioral health platform. The facility has a four-year term.